Search
raxibacumab
Indications:
- treatment & prevention of inhalational anthrax (investigational)
Dosage: 40 mg/kg
Adverse effects:
- allegedly similar to placebo
Mechanism of action:
- monoclonal antibody
Interactions
drug adverse effects of pharmaceutical monoclonal antibodies
General
pharmaceutical monoclonal antibody
References
- Migone T-S et al
Raxibacumab for the treatment of inhalational anthrax.
N Engl J Med 2009 Jul 9; 361:135.
PMID: 19587338
- Nabel GJ.
Protecting against future shock - Inhalational anthrax.
N Engl J Med 2009 Jul 9; 361:191.
PMID: 19587345